Organon & Co.·4

Mar 31, 4:11 PM ET

Nisita Vittorio 4

Research Summary

AI-generated summary

Updated

Organon (OGN) Head Nisita Vittorio Exercises RSUs

What Happened
Nisita Vittorio, Head of Global Business Services at Organon & Co., had 5,762 restricted stock units (RSUs convert to shares) vest on March 29, 2026. Those RSUs converted into 5,762 shares at no cash cost (conversion price $0). To satisfy tax withholding, 1,974 of the shares were surrendered/withheld at an effective price of $5.84 per share, generating $11,528 in tax withholding. After withholding, she received a net 3,788 shares.

Key Details

  • Transaction date: March 29, 2026 (reported on Form 4 filed March 31, 2026).
  • Conversion: 5,762 RSUs converted to 5,762 common shares (derivative exercise/conversion, code M).
  • Tax withholding: 1,974 shares disposed to cover taxes at $5.84 per share = $11,528 (code F). Price $5.84 is the March 27, 2026 closing market price per plan (Footnote F1).
  • Net shares delivered to insider: 3,788 shares (5,762 converted − 1,974 withheld).
  • Footnotes: F2 confirms each RSU equals one share; F3 notes the RSUs vest in three equal annual installments (2025, 2026, 2027).
  • Filing timeliness: Form filed March 31, 2026; filing shows the standard vesting and withholding activity and does not indicate an untimely filing.

Context
This was a routine RSU vesting and tax-withholding event (not an open-market purchase or sale). Converting RSUs to shares at $0 is standard — the withholding of shares to cover taxes is common and should not be read as a deliberate market sale. For retail investors, purchases by insiders generally carry more signal than routine vested awards; here the net effect is Vittorio received 3,788 newly issued shares.